Meds Coupons

View Deals

8 Coupons

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .

    new research shows a growing number of young people are thinking about taking their own lives, and the study suggests school stress may play a role. .[email protected] .

  • .
    . .gravatar .